Clarification sought fromAurobindo Pharma Ltd

The Exchange has sought clarification from Aurobindo Pharma Ltd on March 05, 2018 with reference to news flashed on dated March 05, 2018 quoting "US FDA observations - Aurobindo Unit 4 inspected by US FDA from February 12-20 and issues 9 observations."

The reply is awaited.

Source : BSE -

Published on March 05, 2018


This article is closed for comments.
Please Email the Editor